October 2004, significant progress was achieved in six areas: The First Global Patient Safety Challenge, which for 2005–2006 (addressing health care-associated infection) developed the WHO Guidelines on Hand Hygiene in Health Care. A patient involvement group, Patients for Patient Safety, built networks of patients’ organizations from around the world, through regional workshops. A patient safety taxonomy was developed to classify data on patient safety problems. Prevalence studies conducted on patient harm in ten developing countries. A WHO Collaborating Centre was established to develop and disseminate safety solutions. The WHO Draft Guidelines on Adverse Event Reporting and Learning Systems. Patients for Patient Safety (PFPS) Patients for Patient Safety is part of the World Alliance for Patient Safety launched in 2004 by the WHO. The project emphasizes the central role patients and consumers can play in efforts to improve the quality and safety of healthcare around the world. PFPS works with a global network of patients, consumers, caregivers, and consumer organizations to support patient involvement in patient safety programs, both within countries and in the global programs of the World Alliance for Patient Safety. Australia and New Zealand Therapeutic Goods Administration and Adverse Drug Reactions Advisory Committee The Therapeutic Goods Administration (TGA) is a unit of the Australian Government Department of Health and Ageing. The TGA approves and monitors prescription and non-prescription drugs (including herbal products), medical supplies and devices and blood and biological products. Risks to users are assessed prior to product introduction, and manufacturers are regularly audited for efficacy, quality and safety. Manufacturers are required to report adverse drug effects to the Adverse Drug Reactions Advisory Committee (ADRAC) of the TGA; reporting by medical professionals and consumers is voluntary. ADRAC notifies medical professionals and the public by recalls and alerts on its website and publications. In December 2003, the Australian and New Zealand Governments signed an agreement to establish a joint regulatory organization for therapeutic products. The Australia New Zealand Therapeutic Products Authority (ANZTPA) will replace the Australian Therapeutic Goods Administration (TGA) and the New Zealand Medicines and Medical Devices Safety Authority (Medsafe), and be accountable to the Australian and New Zealand Governments. Implementing legislation is scheduled for introduction into both countries' parliaments in July 2006. On 16 July 2007, the New Zealand State Services Minister Annette King announced that "The Government is not proceeding at this stage with legislation that would have enabled the establishment of a joint agency